RM281 .H57 2010
|
History of vaccine development |
1 |
RM281 .I56 2012
|
Innovation in vaccinology from design, through to delivery and testing / |
1 |
RM281 .M62 1986
|
Model programme for the production of vaccines in developing countries : terminal report / |
1 |
RM281 .M65 2013eb
|
Molecular vaccines. from prophylaxis to therapy / |
1 |
RM281 .M83 2012
|
Mucosal vaccines modern concepts, strategies, and challenges / |
1 |
RM281 .N48
|
New vaccine development : establishing priorities / |
2 |
RM281.P74 1999eb
|
Preliminary Considerations Regarding Federal Investments in Vaccine Purchase and Immunization Services : Interim Report on Immunization Finance Policies and Practices / |
1 |
RM281 .S82 2015eb
|
Subunit vaccine delivery / |
1 |
RM281 .V1
|
Vaccine research and developments. |
1 |
RM281 .V11 1985
|
Vaccine supply and innovation / |
1 |
RM281 .V33 2016
|
Vaccine design : methods and protocols. |
1 |
RM281 .V33 2019
|
Vaccinations / |
1 |
RM281 .W677
|
V & B catalogue / |
1 |
RM281 .W745
|
V&B annual report / |
1 |
RM282.A5 S8 1967
|
Antilymphocytic serum / |
1 |
RM282.C95 B56 1999
|
Biological characterization and assay of cytokines and growth factors : National Institute for Biological Standards and Control, Potters Bar, Herts., U.K., September 10-12, 1997 / |
1 |
RM282.C95 C96 2001
|
Cytokine inhibitors / |
1 |
RM282.C95 C964 2001
|
Cytokine therapeutics in infectious diseases / |
1 |
RM282.C95 C964x 2001
|
Cytokine therapeutics in infectious diseases / |
1 |
RM282.C95 C977 2006
|
Cytokines as potential therapeutic targets for inflammatory skin diseases / |
1 |